SEVERE MUSCLE WEAKNESS DURING TREATMENT WITH PEGYLATED INTERFERON ALFA FOR CHRONIC HEPATITIS C VIRUS INFECTION; A RARE COMPLICATION

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MOBINI N.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Caspian Journal of Internal Medicine Year:2010 | Volume:1 | Issue:3 Page(s): 110-130

Download Full-Text

View:

254

Download:

Cites:

Information Journal Paper

Title

SEVERE MUSCLE WEAKNESS DURING TREATMENT WITH PEGYLATED INTERFERON ALFA FOR CHRONIC HEPATITIS C VIRUS INFECTION; A RARE COMPLICATION

Author(s)

MOBINI N. | Issue Writer Certificate

Keywords

INTERFERON

MUSCLE WEAKNESS

PEGYLATED INTERFERON

MYOPATHY

Abstract

Background: INTERFERONs (IFNs) are common therapeutics for several diseases such as viral hepatitis, multiple sclerosis and malignancy. A variety of autoimmune related side effects has been observed during IFN therapy. Rare cases of MYOPATHY, polymyositis or dermatomyositis have been reported during therapy with high doses of IFNa. Case Presentation: In this report, we describe a case with severe MUSCLE WEAKNESS but near normal muscles' enzymes during treatment of chronic hepatic C infection with pegylated IFN a 2a in a patient with major beta thalassemia.Conclusion: This report suggests that severe weakness with normal musclesα enzymes may occur during IFN therapy.

Cites

SAFETY AND EFFICACY OF ADDING RIBAVIRIN TO INTERFERON OR PEGINTERFERON IN TREATMENT OF HEPATITIS C INFECTION IN PATIENTS WITH THALASSEMIA: A SYSTEMATIC REVIEW ON RANDOMIZED CONTROLLED TRIALS

References

No record.

Cite

APA: Copy

MOBINI, N.. (2010). SEVERE MUSCLE WEAKNESS DURING TREATMENT WITH PEGYLATED INTERFERON ALFA FOR CHRONIC HEPATITIS C VIRUS INFECTION; A RARE COMPLICATION. CASPIAN JOURNAL OF INTERNAL MEDICINE, 1(3), 110-130. SID. https://sid.ir/paper/323185/en

Vancouver: Copy

MOBINI N.. SEVERE MUSCLE WEAKNESS DURING TREATMENT WITH PEGYLATED INTERFERON ALFA FOR CHRONIC HEPATITIS C VIRUS INFECTION; A RARE COMPLICATION. CASPIAN JOURNAL OF INTERNAL MEDICINE[Internet]. 2010;1(3):110-130. Available from: https://sid.ir/paper/323185/en

IEEE: Copy

N. MOBINI, “SEVERE MUSCLE WEAKNESS DURING TREATMENT WITH PEGYLATED INTERFERON ALFA FOR CHRONIC HEPATITIS C VIRUS INFECTION; A RARE COMPLICATION,” CASPIAN JOURNAL OF INTERNAL MEDICINE, vol. 1, no. 3, pp. 110–130, 2010, [Online]. Available: https://sid.ir/paper/323185/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops